米国の医薬品ロジスティクス市場：タイプ・手順・コンポーネント・用途・業務・地域別の機会および予測 (2018-2032年)

米国の医薬品ロジスティクスの市場規模は、2024年の246億9,000万米ドルから、CAGR 7.91％で推移し、2032年には454億米ドルに成長すると予測されています。

この成長の背景には、バイオ医薬品の台頭、コールドチェーン監視技術の急速な進化、臨床試験の分散化が進んでいることが挙げられます。この市場は、現在では世界で最も複雑かつミッションクリティカルなロジスティクス分野のひとつとなりつつあります。高精度、法規制への遵守、温度管理の厳格な維持に支えられた市場構造により、医薬品ロジスティクスは単に製品を運ぶだけでなく、公共の健康を守る役割も果たしています。

当レポートでは、米国の医薬品ロジスティクスの市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分別の詳細分析、ケーススタディ、市場成長への影響因子の分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 米国の関税の影響

第4章 エグゼクティブサマリー

第5章 顧客の声

• 法令遵守
• 品質管理とトレーサビリティ
• 業界での経験と評判
• カスタマーサービスとサポート

第6章 米国の医薬品ロジスティクス市場の展望

• 市場規模の分析・予測
• 市場シェアの分析・予測
  • タイプ別
    • コールドチェーンロジスティクス
    • 非コールドチェーンロジスティクス
  • 手順別
    • ピッキング
    • 保管
    • 検索システム
    • ハンドリングシステム
  • コンポーネント別
    • 保管
    • 輸送
    • 監視コンポーネント
  • 用途別
    • 化学薬品
    • バイオ医薬品
    • 専門医薬品
  • オペレーション別
    • 海路
    • 道路
    • 鉄道
    • 空路
    • 保管・サービス
  • 地域別
    • 北東部
    • 南西部
    • 西部
    • 南東部
    • 中西部
  • 企業別市場シェア分析（上位5社およびその他）
• 市場マップ分析

第7章 需給分析

第8章 バリューチェーン分析

第9章 ポーターのファイブフォース分析

第10章 PESTLE分析

第11章 サービス価格設定モデル

第12章 市場力学

• 市場促進要因
• 市場の課題

第13章 市場動向・発展

第14章 政策と規制状況

第15章 ケーススタディ

第16章 競合情勢

• 上位5社の競合マトリックス
• 上位5社のSWOT分析
• 上位10社の情勢
  • United Parcel Service, Inc.
  • FedEx Corporation
  • DHL Supply Chain & Global Forwarding (Deutsche Post AG)
  • Lineage Logistics Holdings, LLC
  • Americold Realty Trust, Inc.
  • Expeditors International of Washington, Inc.
  • SEKO Logistics, Inc.
  • Owens & Minor, Inc.
  • Penske Truck Leasing Co., L.P. (Penske Logistics)
  • XPO, Inc. (formerly XPO Logistics, Inc.)

第17章 戦略的提言

第18章 調査会社について・免責事項

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. United States Pharmaceutical Logistics Market, By Value, In USD Billion, 2018-2032F
• Figure 2. United States Pharmaceutical Logistics Market Share (%), By Type, 2018-2032F
• Figure 3. United States Pharmaceutical Logistics Market Share (%), By Procedure, 2018-2032F
• Figure 4. United States Pharmaceutical Logistics Market Share (%), By Component, 2018-2032F
• Figure 5. United States Pharmaceutical Logistics Market Share (%), By Application, 2018-2032F
• Figure 6. United States Pharmaceutical Logistics Market Share (%), By Operation, 2018-2032F
• Figure 7. United States Pharmaceutical Logistics Market Share (%), By Region, 2018-2032F
• Figure 8. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
• Figure 9. By Procedure Map-Market Size (USD Billion) & Growth Rate (%), 2024
• Figure 10. By Component Map-Market Size (USD Billion) & Growth Rate (%), 2024
• Figure 11. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2024
• Figure 12. By Operation Map-Market Size (USD Billion) & Growth Rate (%), 2024
• Figure 13. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024

United States pharmaceutical logistics market is projected to witness a CAGR of 7.91% during the forecast period 2025-2032, growing from USD 24.69 billion in 2024 to USD 45.40 billion in 2032F, owing to biologics taking center stage, rapid innovations in cold chain monitoring, and increasingly distributed clinical trial activity. This market has quietly become one of the most complex and mission-critical logistics sectors globally. With a market built on precision, compliance, and temperature integrity, pharmaceutical logistics in the United States not only moves goods but also safeguards public health.

For instance, in April 2025, DHL Group announced a USD 2.3 billion (EUR 2 billion) strategic investment over the next five years to boost its logistics capabilities in the life sciences and healthcare sector. Supporting its "Strategy 2030," the investment will enhance DHL's infrastructure, technology, and cold chain solutions globally, with 50% allocated to the Americas and the remainder to other regions.

Cold Chain Infrastructure Expansion to Meet Biologic and Vaccine Demands Leads to Market Growth

Biopharmaceuticals and vaccine logistics have emerged as key growth areas in the United States pharmaceutical logistics, driven by heightened demand for temperature-sensitive therapies and the need for ultra-cold storage. For instance, in April 2024, Americold Realty Trust broke ground on a new 335,000-square-foot temperature-controlled facility in Missouri, in partnership with CPKC Rail. A few of the facility's features include deep-frozen zones, real-time monitoring, and rail access right outside the door. All designed to keep cross-border pharma moving, fast, safe, and at the right temperature. Every detail screams pharma-grade-nothing left to chance. These investments reflect a broader trend as cold storage is now central to logistics strategy, not just an operational add-on.

Increasing Regulatory Compliance and Certification for Pharma Handling

United States logistics firms are actively investing in globally recognized pharma certifications to win high-value contracts and ensure compliance with stringent domestic and international handling protocols. For instance, in May 2025, FedEx became the first global integrator to earn IATA CEIV Pharma corporate certification for its entire ground-handling network. This move reinforced its leadership in temperature-sensitive and compliant logistics. This milestone underscores how compliance has become a key competitive advantage. With increasing FDA scrutiny and pharmaceutical clients demanding zero-defect delivery, certified partners are becoming the default.

Specialized Pharma Driving Service Differentiation Across Logistics Chains

Specialized pharmaceuticals, from gene therapies and personalized oncology drugs to treatments for rare diseases, are reshaping the United States logistics landscape. These products demand ultra-narrow handling tolerances, GPS-enabled real-time monitoring, and delivery windows that leave no margin for error. In April 2025, United Parcel Service, Inc. expanded its specialty temperature-controlled facilities and specialized in cold chain transportation network through the acquisition of Andlauer Healthcare Group Inc. for USD 1.6 billion. This acquisition will enhance our end-to-end capabilities and services to healthcare customers requiring temperature-controlled logistics solutions in United States.

This reflects a larger trend, as therapies get more individualized, so must the logistics behind them. Custom kitting, end-to-end tracking, and validated SOPs are no longer differentiators; they are minimum requirements.

Impact of U.S. Tariffs on United States Pharmaceutical Logistics Market

Tariffs on imported APIs, medical supplies, and logistics equipment increase production and transportation expenses. Pharma companies often pass these costs to consumers, leading to rising drug prices.

Dependence on China and India for APIs forces companies to diversify suppliers or shift production to the U.S./Mexico. Temporary shortages and stockpiling occur due to trade uncertainties.

Refrigeration units, packaging materials, and tracking devices become more expensive due to tariffs. Increased demand for U.S.-based cold storage as companies hold more inventory domestically.

Switching suppliers requires FDA reapprovals, slowing down drug distribution. Companies invest in AI, blockchain, and nearshoring to optimize tariff-affected supply chains.

Key Players Landscape and Outlook

Major players dominate the United States pharmaceutical logistics market, with some being global and others homegrown. They promise cold chain warehousing, certified transport, and real-time tracking. They cater to biologics, vaccines, and clinical trials. Then you have the cold storage experts. Americold and Lineage Logistics are investing heavily, expanding, automating, and upgrading for the pharmaceutical industry. SEKO Logistics and Expeditors are tightening air-cargo links. Owens & Minor, All about medical fulfillment and hospital supplies. Personalized medicine is booming. Temperature-sensitive therapies are everywhere. Regulations are more challenging than ever. Now, it is not just about trucks and warehouses; it is about compliance, traceability, and speed.

For instance, in April 2025, Lineage, Inc. announced a significant expansion of its United States cold-storage network through a series of acquisitions, greenfield developments, and advanced automation projects. As part of this initiative, Lineage has entered a definitive agreement to acquire multiple cold storage warehouses from Tyson Foods, Inc., strengthening its longstanding partnership. Additionally, Lineage will design, build, and operate two next-generation, fully automated cold storage facilities in key United States distribution markets, with Tyson Foods serving as the anchor tenant. Lineage plans to invest approximately USD 1 billion in these acquisitions and new developments over the coming years.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of U.S. Tariffs

4. Executive Summary

5. Voice of Customers

• 5.1. Regulatory Compliance
• 5.2. Quality Management and Traceability
• 5.3. Industry Experience and Reputation
• 5.4. Customer Service and Support

6. United States Pharmaceutical Logistics Market Outlook, 2018-FY2032F

• 6.1. Market Size Analysis & Forecast
  • 6.1.1. By Value
• 6.2. Market Share Analysis & Forecast
  • 6.2.1. By Type
    • 6.2.1.1. Cold Chain Logistics
    • 6.2.1.2. Non-Cold Chain Logistics
  • 6.2.2. By Procedure
    • 6.2.2.1. Picking
    • 6.2.2.2. Storage
    • 6.2.2.3. Retrieval Systems
    • 6.2.2.4. Handling Systems
  • 6.2.3. By Component
    • 6.2.3.1. Storage
    • 6.2.3.2. Transportation
    • 6.2.3.3. Monitoring Components
  • 6.2.4. By Application
    • 6.2.4.1. Chemical Pharma
    • 6.2.4.2. Biopharma
    • 6.2.4.3. Specialized Pharma
  • 6.2.5. By Operation
    • 6.2.5.1. Seaways
    • 6.2.5.2. Roadways
    • 6.2.5.3. Railways
    • 6.2.5.4. Airways
    • 6.2.5.5. Storage and Services
  • 6.2.6. By Region
    • 6.2.6.1. Northeast
    • 6.2.6.2. Southwest
    • 6.2.6.3. West
    • 6.2.6.4. Southeast
    • 6.2.6.5. Midwest
  • 6.2.7. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
• 6.3. Market Map Analysis, 2024
  • 6.3.1. By Type
  • 6.3.2. By Procedure
  • 6.3.3. By Component
  • 6.3.4. By Application
  • 6.3.5. By Operation
  • 6.3.6. By Region

7. Demand Supply Analysis

8. Value Chain Analysis

9. Porter's Five Forces Analysis

10. PESTLE Analysis

11. Service Pricing Model

12. Market Dynamics

• 12.1. Market Drivers
• 12.2. Market Challenges

13. Market Trends and Developments

14. Policy and Regulatory Landscape

15. Case Studies

16. Competitive Landscape

• 16.1. Competition Matrix of Top 5 Market Leaders
• 16.2. SWOT Analysis for Top 5 Players
• 16.3. Key Players Landscape for Top 10 Market Players
  • 16.3.1. United Parcel Service, Inc.
    • 16.3.1.1. Company Details
    • 16.3.1.2. Key Management Personnel
    • 16.3.1.3. Products and Services
    • 16.3.1.4. Financials (As Reported)
    • 16.3.1.5. Key Market Focus and Geographical Presence
    • 16.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 16.3.2. FedEx Corporation
  • 16.3.3. DHL Supply Chain & Global Forwarding (Deutsche Post AG)
  • 16.3.4. Lineage Logistics Holdings, LLC
  • 16.3.5. Americold Realty Trust, Inc.
  • 16.3.6. Expeditors International of Washington, Inc.
  • 16.3.7. SEKO Logistics, Inc.
  • 16.3.8. Owens & Minor, Inc.
  • 16.3.9. Penske Truck Leasing Co., L.P. (Penske Logistics)
  • 16.3.10. XPO, Inc. (formerly XPO Logistics, Inc.)

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

17. Strategic Recommendations

18. About Us and Disclaimer